Science Explorer Back to mapMap
Discussion
Researcher · Shikoku Cancer Center · Japan

Tomohiro Nishina

Tomohiro Nishina publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes and Cancer Genomics and Diagnostics.

ORCID 0000-0002-4073-3757 OpenAlex
World rank
#373,840
of 7,710,434 ranked researchers
Rank in Japan
#3,393
of 383,136
Works
504
Citations
11k
Citations per work
20.9
h-index
48
i10-index 133Top 4.1% in Oncology
Tomohiro Nishina

What does Tomohiro Nishina research?

Tomohiro Nishina's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 352 works · 69.8% of their workMedicine: 352 works · 69.8% of their workOncology: 164 works · 32.5% of their workPulmonary and Respiratory Medicine: 112 works · 22.3% of their workSurgery: 55 works · 11.0% of their workPathology and Forensic Medicine: 20 works · 4.0% of their workEverything else: 99 works · 19.7% of their workLife Sciences: 53 works · 10.5% of their workBiochemistry, Genetics and Molecular Biology: 53 works · 10.5% of their workCancer Research: 32 works · 6.3% of their workMolecular Biology: 21 works · 4.2% of their workTHEIR WORKTomohiro Nishina504works
Life Sciences10%Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine35269.8%
  2. Everything else9919.7%
    1. Biochemistry, Genetics and Molecular Biology5310.5%
  1. 1Oncology32% of their works
  2. 2Pulmonary and Respiratory Medicine22% of their works
  3. 3Surgery11% of their works
  4. 4Cancer Research6% of their works
  5. 5Molecular Biology4% of their works
  6. 6Pathology and Forensic Medicine4% of their works

Research topics

Which keywords describe Tomohiro Nishina's research?

The keywords of their largest research topics: Chemotherapy, Molecular Characterization, Cetuximab, KRAS Mutations, Endoscopic Resection, Gastric Cancer, Lymph Node Dissection and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy3713 topics
  2. Molecular Characterization1892 topics
  3. Cetuximab1841 topic
  4. KRAS Mutations1841 topic
  5. Endoscopic Resection1802 topics
  6. Gastric Cancer1491 topic
  7. Lymph Node Dissection1491 topic
  8. Targeted Therapy1162 topics
  9. Cancer Genomics651 topic
  10. Mutational Signatures651 topic
  11. ALK Inhibitors511 topic
  12. EGFR Mutations511 topic
  13. Hereditary Syndromes401 topic
  14. Microsatellite Instability401 topic
  15. Breast Cancer381 topic
  16. Chemotherapy-Induced Peripheral Neuropathy381 topic
  17. HER2381 topic
  18. Taxanes381 topic
  19. Esophageal Carcinoma311 topic
  20. Preoperative Chemoradiotherapy311 topic

Where does Tomohiro Nishina work?

Tomohiro Nishina's main affiliation in the publication record is Shikoku Cancer Center, Japan.

How many publications and citations does Tomohiro Nishina have?

OpenAlex counts 504 works and 10,523 citations for Tomohiro Nishina, an h-index of 48, ranking #373,840 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Tomohiro Nishina

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Tomohiro Nishina. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.